June 2014
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Navigating Migraine Management and the Role of Symbravo in Acute Treatment
3
FDA Approves Enfortumab Vedotin Plus Pembrolizumab for Muscle-Invasive Bladder Cancer
4
FDA Approves Gene Replacement Therapy Itvisma for Patients With Spinal Muscular Atrophy
5
